Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_assertion type Assertion NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_head.
- NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_assertion description "[Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_provenance.
- NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_assertion evidence source_evidence_literature NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_provenance.
- NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_assertion SIO_000772 18829562 NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_provenance.
- NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_assertion wasDerivedFrom befree-20150227 NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_provenance.
- NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_assertion wasGeneratedBy ECO_0000203 NP482837.RADtISnwPfK34ykh2UhJ_siZ9h6NIlHL-DTw-u0vgrKTk130_provenance.